Emergent BioSolutions Inc. (EBS) › EPS (Basic)Emergent BioSolutions Inc. (EBS) — EPS (Basic)Annual figures by period end, from SEC filings.2009-12-31: $1.022010-12-31: $1.632011-12-31: $0.652012-12-31: $0.652013-12-31: $0.862014-12-31: $0.982015-12-31: $1.632016-12-31: $1.292017-12-31: $1.982018-12-31: $1.252019-12-31: $1.062020-12-31: $5.802021-12-31: $4.102022-12-31: $-4.222023-12-31: $-14.852024-12-31: $-3.602025-12-31: $0.98$0.982009-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$0.98—2026-02-27From 2025-01-012024-12-31$-3.60—2026-02-27From 2024-01-012023-12-31$-14.85—2026-02-27From 2023-01-012022-12-31$-4.22-202.9%2025-03-04From 2022-01-012021-12-31$4.10-29.3%2024-03-08From 2021-01-012020-12-31$5.80+447.2%2023-12-11From 2020-01-012019-12-31$1.06-15.2%2022-02-25From 2019-01-012018-12-31$1.25-36.9%2021-02-19From 2018-01-012017-12-31$1.98+53.5%2020-02-25From 2017-01-012016-12-31$1.29-20.9%2019-02-22From 2016-01-012015-12-31$1.63+66.3%2018-02-23From 2015-01-012014-12-31$0.98+14.0%2017-02-28From 2014-01-012013-12-31$0.86+32.3%2016-02-29From 2013-01-012012-12-31$0.65+0.0%2015-03-09From 2012-01-012011-12-31$0.65-60.1%2014-03-10From 2011-01-012010-12-31$1.63+59.8%2013-03-08From 2010-01-012009-12-31$1.02—2012-03-09From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares